Mark Asset Management LP Pfizer Inc Transaction History

Mark Asset Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $1.91 Million - $2.37 Million	-41,760 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $815,450 - $1.21 Million	19,735 Added 89.6%	41,760 $2.47 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $393,481 - $505,460	10,025 Added 83.54%	22,025 $947,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $430,919 - $488,160	12,000 New	12,000 $470,000

3,261

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Mark Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Mark Asset Management LP with notifications on news.